Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218049 · ClinicalTrials.gov registry record · Phase 1
Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals
A Phase 1 study, sponsored by National Institute on Drug Abuse (NIDA).
- Terminated
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT00218049 is a Phase 1 study that was terminated before completion, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 3 participants.
The verdict
NCT00218049, a Phase 1 study, was terminated before completion, sponsored by National Institute on Drug Abuse (NIDA).
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
Cocaine dependence is a major public health problem; an effective primary treatment for cocaine dependent individuals has yet to be found. The purpose of this study is to determine the safety and effects of vanoxerine (GBR 12909) in treating cocaine dependent individuals.
Interventions
- DRUG GBR 12909
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2004-12 |
| Est. Completion | 2005-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00218049
The ClinicalTrials.gov registry entry for NCT00218049 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GBR 12909 is the first listed.
NCT00218049 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00218049 about?
NCT00218049 is a clinical study titled "Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals". Cocaine dependence is a major public health problem; an effective primary treatment for cocaine dependent individuals has yet to be found. The purpose of this study is to determine the safety and effects of vanoxerine (GBR 12909) in treating cocaine dependent individuals.
What is the current status of trial NCT00218049?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2004-12. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00218049?
The interventions under investigation include: GBR 12909 (DRUG).
Who is sponsoring clinical trial NCT00218049?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.